N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4-aminomethyl-benzamide | 537707-66-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4-aminomethyl-benzamide
• 英文别名: 4-(aminomethyl)-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)benzamide
• CAS: 537707-66-7
• 化学式: C₂₀H₂₂N₄O₃S
• 分子量: 398.486
• InChiKey: PRGIYUWSMBGTDW-UHFFFAOYSA-N

物化性质

• 密度：
  1.362±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  118
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4-aminomethyl-benzamide 、 环丁基甲酰氯 以52%的产率得到4-[(cyclobutanecarbonyl-amino)-methyl]-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-benzamide
  参考文献：
  名称：

  BENZOTHIAZOLE DERIVATIVES

  摘要：

  本发明涉及公式1的化合物，其中R1和R2如本文所定义。公式I的化合物被发现是腺苷受体配体。具体来说，本发明的化合物对A2A受体具有良好的亲和力，因此它们在治疗与该受体相关的疾病方面是有用的。

  公开号：

  US20030134855A1

文献信息

• Benzothiazole derivatives
  申请人：Hoffman-La Roche Inc.

  公开号：US06624163B2

  公开（公告）日：2003-09-23

  The present invention relates to compounds of the formula wherein R1 and R2 are as defined herewithin. The compounds of formula I have been found to be adenosine receptor ligands. Specifically, the compounds of the present invention have a good affinity to the A2A-receptor and they are therefore useful in the treatment of diseases, related to this receptor.

  本发明涉及公式I的化合物，其中R1和R2的定义如下。公式I的化合物已被发现是腺苷受体配体。具体而言，本发明的化合物对A2A受体具有良好的亲和力，因此它们在治疗与该受体相关的疾病方面是有用的。
• US6624163B2
  申请人：——

  公开号：US6624163B2

  公开（公告）日：2003-09-23
• [EN] BENZOTHIAZOLE DERIVATIVES<br/>[FR] DERIVES DE BENZOTHIAZOLE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2003045386A1

  公开（公告）日：2003-06-05

  The present invention relates to compounds of the general formula (I) wherein R1 is hydrogen or lower alkyl; R2 is lower alkyl, -(CH¿2?)n-O-lower alkyl, -C3-6-cycloalkyl or -(CH2)n-NR'2; R' is hydrogen, lower alkyl or -(CH2)n-O-lower alkyl, independently from each other for R'2, or R'2 may form together with the N atom a pyrrolidine ring; n is l, 2 or 3; and to pharmaceutically acceptable acid addition salts thereof. It has surprisingly been found that the compounds of general formula I are adenosine receptor ligands. Specifically, the compounds of the present invention have a good affinity to the A2A-receptor and they are therefore useful in the treatment of diseases, related to this receptor.
• BENZOTHIAZOLE DERIVATIVES
  申请人：——

  公开号：US20030134855A1

  公开（公告）日：2003-07-17

  The present invention relates to compounds of the formula 1 wherein R 1 and R 2 are as defined herewithin. The compounds of formula I have been found to be adenosine receptor ligands. Specifically, the compounds of the present invention have a good affinity to the A 2A -receptor and they are therefore useful in the treatment of diseases, related to this receptor.

  本发明涉及公式1的化合物，其中R1和R2如本文所定义。公式I的化合物被发现是腺苷受体配体。具体来说，本发明的化合物对A2A受体具有良好的亲和力，因此它们在治疗与该受体相关的疾病方面是有用的。